ClinicalTrials.Veeva

Menu

Correlation of Gene Status and Clinical Outcomes in ESCC

L

LiuJunFeng

Status

Unknown

Conditions

Prognosis of Patients With ESCC

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03831828
HebeiMUFH-ESCC

Details and patient eligibility

About

The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.

Enrollment

46 estimated patients

Sex

All

Ages

30 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Esophageal cancer patients who underwent surgery treatment, and postoperative pathological diagnosis was squamous cell carcinoma. Patients with ESCC have complete clinical information.

Exclusion criteria

  • Patients who also suffering from other tumors.

Trial design

46 participants in 2 patient groups

Lymph node metastasis Positive
Description:
good prognosis; without Lymph node metastasis.
Lymph node metastasis Negative
Description:
poor prognosis; with Lymph node metastasis.

Trial contacts and locations

1

Loading...

Central trial contact

Junfeng Liu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems